Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 24, 2023
March 27, 2023
adf9cb72-5955-4d5f-8f26-4e226281ace9
Related Documents
Tissue Agnostic Drug Development in Oncology: Draft Guidance for Industry
Guidance DocumentOctober 17, 2022Office of the Commissioner
Accelerated Approval and Considerations for Determining Whether a Confirmatory Trial is Underway
Guidance DocumentJanuary 7, 2025Office of the Commissioner
Considerations for Generating Clinical Evidence from Oncology Multiregional Clinical Development Programs
Guidance DocumentSeptember 16, 2024Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.